Steven Fishbane, MD, Chief of Nephrology, Northwell Health, Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell.
Stephen Brunton, MD, FAAFP, Executive Director, Primary Care Metabolic Group.
J Fam Pract. 2022 Jul;71(6 Suppl):S23-S28. doi: 10.12788/jfp.0411.
At the end of the activity, participants will be able to:Describe approaches to improve recognition of chronic kidney disease (CKD) and anemia in primary care. Explain the importance of early management of anemia in CKD to reduce adverse outcomes and improve symptoms. Prescribe evidence-based treatment for patients with anemia in CKD who can be managed in the primary care setting. Discuss emerging evidence for new agents being studied for treating anemia in CKD.
在活动结束时，参与者将能够：
描述改善初级保健中慢性肾脏病 (CKD) 和贫血识别的方法。
解释早期管理 CKD 贫血以减少不良后果和改善症状的重要性。
为可以在初级保健环境中管理的 CKD 贫血患者开具基于证据的治疗方案。
讨论正在研究用于治疗 CKD 贫血的新药物的新证据。
